These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 23063511)

  • 21. Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.
    Gole B; Durán Alonso MB; Dolenc V; Lah T
    Pathol Oncol Res; 2009 Dec; 15(4):711-23. PubMed ID: 19434518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
    Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
    Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
    Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
    Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose.
    Jung M; Lee J; Seo HY; Lim JS; Kim EK
    PLoS One; 2015; 10(1):e0116972. PubMed ID: 25625842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro.
    Teti A; De Giorgi A; Spinella MT; Migliaccio S; Canipari R; Onetti Muda A; Faraggiana T
    Int J Cancer; 1997 Sep; 72(6):1013-20. PubMed ID: 9378535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells.
    Sokol JP; Schiemann WP
    Mol Cancer Res; 2004 Mar; 2(3):183-95. PubMed ID: 15037657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term cyclosporin A exposure suppresses cathepsin-B and -L activity in gingival fibroblasts.
    Yamaguchi M; Naruishi K; Yamada-Naruishi H; Omori K; Nishimura F; Takashiba S
    J Periodontal Res; 2004 Oct; 39(5):320-6. PubMed ID: 15324353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma growth and progression after ultraviolet a irradiation: impact of lysosomal exocytosis and cathepsin proteases.
    Eding CB; Domert J; Wäster P; Jerhammar F; Rosdahl I; Öllinger K
    Acta Derm Venereol; 2015 Sep; 95(7):792-7. PubMed ID: 25669167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
    Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC
    Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
    Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
    Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
    Colella R; Jackson T; Goodwyn E
    Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.
    Yamane K; Ihn H; Asano Y; Jinnin M; Tamaki K
    J Immunol; 2003 Oct; 171(7):3855-62. PubMed ID: 14500687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression.
    Panza E; De Cicco P; Armogida C; Scognamiglio G; Gigantino V; Botti G; Germano D; Napolitano M; Papapetropoulos A; Bucci M; Cirino G; Ianaro A
    Pigment Cell Melanoma Res; 2015 Jan; 28(1):61-72. PubMed ID: 25205294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
    Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
    BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of TGF-β signaling in clear cell renal cell carcinoma cells.
    Boström AK; Lindgren D; Johansson ME; Axelson H
    Biochem Biophys Res Commun; 2013 May; 435(1):126-33. PubMed ID: 23618868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells.
    Reddy KB; Krueger JS; Kondapaka SB; Diglio CA
    Int J Cancer; 1999 Jul; 82(2):268-73. PubMed ID: 10389762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.
    Schmid P; Itin P; Rufli T
    Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.